HEALTH CARE:
BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
Mirati Therapeutics, Inc. is a biopharmaceutical company that discovers, develops, and commercializes novel therapeutics with an initial focus on cancer and infectious diseases.
| Market Cap | 3.669 Billion | Shares Outstanding | 39.44 Million | Avg Volume | 892.423 Thousand |
| 1-Yr BETA vs S&P TR | 1.015 | Current Ratio | 8.67 | Quick Ratio | 8.67 |
| Mirati Therapeutics Inc Chart by YCharts | |
| Yahoo! Finance | finviz |
| SEC Web Site | SEC DEF 14A Filings |
Please sign in first
none
none
18 Thousand total shares from 9 transactions
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
CHRISTENSEN JAMIE EVP, CHIEF SCIENTIFIC OFFICER |
|
32,842 | 2020-03-26 | 3 |
|
FUCHS HENRY J PRESIDENT, WORLDWIDE R&D |
|
139,869 | 2020-03-20 | 1 |
|
24,613,516 | 2020-03-20 | 1 | |
|
RINGO WILLIAM R CHIEF EXECUTIVE OFFICER |
|
0 | 2020-03-19 | 0 |
|
9,062,225 | 2020-03-18 | 0 | |
|
4,310,689 | 2020-03-17 | 0 | |
|
BAUM CHARLES M PRESIDENT & CEO |
|
104,175 | 2020-02-28 | 6 |
|
0 | 2020-02-26 | 4 | |
|
CHEN ISAN EVP, CHIEF MEDICAL OFFICER |
|
39,401 | 2020-01-29 | 1 |
|
1,765,560 | 2020-01-10 | 2 | |
|
0 | 2020-01-09 | 1 | |
|
HICKEY BENJAMIN EVP, CHIEF COMMERCIAL OFFICER |
|
0 | 2020-01-06 | 2 |
|
FAGA DANIEL EVP, CHIEF OPERATING OFFICER |
|
0 | 2020-01-06 | 2 |
|
REED VICKIE S SVP, CHIEF ACCOUNTING OFFICER |
|
8,250 | 2020-01-06 | 2 |
|
|
4,256 | 2020-01-03 | 4 | |
|
|
39,052 | 2020-01-03 | 1 | |
|
|
2,000 | 2020-01-03 | 1 | |
|
|
3,000 | 2020-01-03 | 1 | |
|
|
2,000 | 2020-01-03 | 3 | |
|
253,338 | 2019-07-11 | 3 | |
|
4,685,574 | 2019-07-01 | 0 | |
|
0 | 2019-06-05 | 0 | |
|
DONADIO JAMIE A SR. VP, CFO |
|
221 | 2019-05-16 | 1 |
|
203,754 | 2019-04-04 | 1 | |
|
87,607 | 2019-04-04 | 1 | |
|
3,135,966 | 2019-03-01 | 0 | |
|
LEMASTERS CHRISTOPHER C. EVP, CHIEF BUSINESS OFFICER |
|
0 | 2019-02-14 | 0 |
|
|
0 | 2019-01-17 | 0 | |
|
2,978,762 | 2018-12-21 | 0 | |
|
1,868,966 | 2017-11-20 | 0 | |
|
3,135,966 | 2017-11-16 | 0 | |
|
513,630 | 2017-10-03 | 1 | |
|
513,630 | 2017-10-03 | 0 | |
|
0 | 2017-09-21 | 0 | |
|
GERGEN MARK J SVP, CHIEF OPERATING OFFICER |
|
0 | 2017-02-22 | 0 |
|
680,424 | 2017-01-06 | 0 | |
|
757,935 | 2016-03-17 | 0 | |
|
1,680,515 | 2016-01-14 | 0 | |
|
1,665,024 | 2016-01-14 | 0 | |
|
1,232,984 | 2016-01-14 | 0 | |
|
2,975,072 | 2016-01-04 | 0 | |
|
951,840 | 2015-09-16 | 0 |
| Reporting Owners | Transaction Date | Transaction Code | Shares | Share Price | Acquired or Disposed | Shares Owned Following Transaction | Combined shares owned after filing | Direct/Indirect Ownership | 10b-5 |
|---|---|---|---|---|---|---|---|---|---|
| 2020-03-26 | M | 1,250 | d | 13,750 | 32,842.00 | direct | |||
| 2020-03-26 | M | 1,256 | d | 13,747 | 32,842.00 | direct | |||
| 2020-03-26 | M | 888 | $17.41 | a | 31,592 | 32,842.00 | direct | ||
| 2020-03-26 | M | 2,580 | $24.99 | a | 27,364 | 32,842.00 | direct | ||
| 2020-03-26 | M | 888 | d | 12,879 | 32,842.00 | direct | |||
| 2020-03-26 | M | 2,580 | d | 42,420 | 32,842.00 | direct | |||
| 2020-03-26 | M | 2,084 | $5.40 | a | 30,704 | 32,842.00 | direct | ||
| 2020-03-26 | M | 2,084 | d | 26,041 | 32,842.00 | direct | |||
| 2020-03-26 | M | 1,250 | $21.51 | a | 32,842 | 32,842.00 | direct | ||
| 2020-03-26 | M | 1,256 | $5.50 | a | 28,620 | 32,842.00 | direct | ||
| 2020-02-28 | M | 2,291 | d | 105,413 | 104,175.00 | direct | |||
| 2020-02-28 | M | 2,291 | $5.40 | a | 104,175 | 104,175.00 | direct | ||
| 2020-02-04 | M | 2,396 | d | 111,652 | 101,884.00 | direct | |||
| 2020-02-04 | M | 2,291 | $5.40 | a | 99,488 | 101,884.00 | direct | ||
| 2020-02-04 | M | 2,291 | d | 107,704 | 101,884.00 | direct | |||
| 2020-02-04 | M | 2,396 | $24.99 | a | 101,884 | 101,884.00 | direct | ||
| 2020-01-29 | M | 3,002 | $24.99 | a | 39,401 | 39,401.00 | direct | ||
| 2020-01-29 | M | 3,002 | d | 56,754 | 39,401.00 | direct |
